Specifically, we previously have shown that genetic variation in the rate-limiting enzyme in folate metabolism, methylenetetrahydrofolate (MTHFR), as well as endothelial nitric oxide synthetase (eNOS) is associated with a greater risk for endothelial dysfunction, a predictor of cardiovascular morbidity and mortality. The gene discussed is MTHFR; the disease is endothelial dysfunction.